|2.83|| +0.11 / +4.04%|
Organovo Holdings, Inc. is a biotechnology company, which designs and creates functional and three-dimensional human tissues for medical research and therapeutic applications. It also develops and commercializes a platform technology for the generation of three-dimensional human tissues that can be employed in drug discovery and development, biological research, and as therapeutic implants for the treatment of damaged or degenerating tissues and organs. The company collaborates with pharmaceutical and academic partners to develop human biological disease models in three dimensions. Organovo Holdings was founded on January 30, 2012 and is headquartered in San Diego, CA.
|Keith Murphy||Chairman, President & Chief Executive Officer|
|Sharon Collins Presnell||Chief Scientific Officer|
|Jennifer Kinsbruner Bush||Secretary, General Counsel & Compliance Officer|
|Eric Michael David||Chief Strategy Officer|
|Paul Gallant||GM-Vitro Tissue Services|